Incisive Health’s Post

🇪🇺 Attending the Euronews Health Summit today, where one of the key discussions is about aligning Europe's industrial strategy with the pharmaceutical sector to tackle issues like medicine shortages and dependencies on third countries.   The big question is: how do we ensure an efficient Critical Medicines Act? The consensus is that the Pharma Strategy must be connected with the Industrial Strategy. This alignment is key to boosting competitiveness, fostering innovation, and reducing dependencies on the US and China.   As Draghi highlighted, revitalising Europe’s industrial strategy is crucial for growth and competition, and this link is crucial to ensuring the future of healthcare in the EU.   #EUHealth #EuronewsSummit   Get in touch with us to find out more.

🇪🇺It’s The Parliament Health Summit day and we’re here to get the latest from a great speaker roster. What’s next for the European #HealthUnion? How will health policymaking evolve in the new mandate? 🗣️A message from Health Commissioner Stella Kyriakides to kick it off: “I would like very much to see health continue to be at the top of the political agenda in the EU and to see that we deliver what citizens expect on health” #PMHealth

As the Conservatives meet in Birmingham to decide the future of the party, Incisive Health's James Maxwell shares his reflections on the mood of the governing Labour Party at last week's conference in Liverpool, and how the new health team is fairing. https://lnkd.in/eGU8YgF6

🇪🇺 We are happy to introduce Ana-Maria G. as our new EU Health Policy Trainee. Ana-Maria brings a legal background and valuable experience from the European Commission, combined with a passion for health policies.   As a writer and managing editor for a student think tank, Ana-Maria gained insights into EU decision-making processes, particularly in the areas of environment and health.    Now, she is ready to start her journey with us, and we're excited to have her on board!   Welcome to the team, Ana-Maria! 👏  

🇪🇺🇧🇪 Our Senior Account Executive Maria Brandão is back from Strasbourg! It’s been an eventful and insightful week at the European Parliament plenary session, where the value of in-person connections—meeting with colleagues and policymakers—was a true highlight. From discussions on European competitiveness to reactions to the newly announced College of Commissioners, there was plenty to reflect on.   The new College of Commissioners will play a pivotal role in shaping policy in the coming years, and there’s plenty to anticipate. The decision to create a Health and Animal Welfare Commissioner, under the guidance of the Executive Vice President for People Skills and Preparedness and the Executive Vice President for Clean, Just, and Competitive Transition and the appointment of Olivér Várhelyi came as a surprise and raised some eyebrows.    In this role, the new Commissioner will oversee DG SANTE and DG HERA, focusing on strengthening the European Health Union, improving access to advanced treatments, tackling supply chain diversification and drug shortages, and finalizing crucial initiatives such as the General Pharmaceutical Legislation, the European Health Data Space, and Europe’s Beating Cancer Plan. He will also lead efforts on a new European Biotech Act and a Critical Medicines Act.   While European Competitiveness was high on the agenda, with Mario Draghi in attendance, it was evident that the pharmaceutical sector didn’t receive the attention it urgently needs. The need to prioritize health within the European agenda is clear. Now is the time to push harder to ensure that health remains a key priority in this mandate and continue to advocate for a stronger, more resilient European Health Union. 🩺

🔶 Following their recent electoral success, have you found yourself wondering what will the Liberal Democrats do next? Our Associate Director Claire Hastings reports back from the party's all-singing, all-dancing autumn conference on what the road to 2029 looks like for the Liberal Democrats: leading with health; building economic credibility; challenging on Europe? And will that be enough to deliver the ‘Tory annihilation’ threatened by party leader Sir Ed Davey in his closing speech? Read more here: https://lnkd.in/eWiBPhe3 Do look out for more of our updates from the 2024 party conferences, and if you have any questions for the team, don't hesitate to get in touch via [email protected]. #UKpolitics #liberaldemocrats #partyconference #ukpublicaffairs

🌍 Incisive Health is out in force at the World Cancer Congress - supporting a number of events -bringing together key thought leaders in global health #wcc #globalhealth #cancercontrol #healthliteracy #womenshealth #healthequity

🇪🇺📢 Live from Strasbourg: Our team is attending this week’s plenary session! Maria Brandão is on site closely following the critical discussions on the future of European Competitiveness and reactions to the newly announced College of Commissioners, including the incoming Health Commissioner, Olivér Várhelyi from Hungary. Interested in connecting and discussing the latest developments? Reach out for a coffee ☕️

The Darzi report is the first major health policy milestone for the Labour government. It lays bare the scale of the challenge facing the NHS and it is clear that there will not be any quick or easy fixes – read our latest blog from Head of UK Practice Ed McIntosh on the difficult task now faced by Wes Streeting: https://lnkd.in/eJejXnFh If you have any questions for the team, or would like advice or support, please do get in touch via [email protected]. #Darzireview #NHS #UKPolitics

🇪🇺 Yesterday, Mario Draghi, former Italian Prime Minister and ex-ECB President, presented his much-anticipated report on the future of EU competitiveness, highlighting the urgent need for Europe to take action or risk falling behind global powers like the U.S. and China.    His message? Europe needs to revamp its industrial strategy by cutting bureaucracy, driving innovation, and creating a more business-friendly environment.   One of the key sectors in the spotlight is pharmaceuticals, which Draghi highlights as a crucial pillar of the EU’s economy. But despite its strong history, Europe is starting to fall behind in fast-growing areas like biologics and advanced therapies, where U.S. companies are leading the way.   So, what does this mean for the pharmaceutical sector? How will Draghi's vision shape the future of pharma in Europe? 👇 Keep reading to find out more!